β 2-adrenoceptors, NADPH oxidase, ROS and p38 MAPK: Another 'radical' road to heart failure?

Fabio Di Lisa, Nina Kaludercic, Nazareno Paolocci

Research output: Contribution to journalReview articlepeer-review

Abstract

Persistent activation of the cardiac β-adrenergic system may contribute to the pathogenesis of congestive heart failure. Both β 1- and β 2-adrenoceptors are known to mediate these noxious effects, yet the β 1-adrenoceptor-PKA axis has received greater attention with less information available on β 2-adrenoceptor driven pathways. In the present issue, Xu and colleagues provide new evidence, showing that β 2-adrenoceptor over-expression leads to increased reactive oxygen species (ROS) emission, mainly caused by up-regulation of reduced nicotinamide adenine dinucleotide phosphate oxidase (Nox) 2 and 4. Increase in ROS levels is accompanied by p38 mitogen-activated protein kinase activation, fibrosis, apoptosis and cardiac dysfunction. Both Nox inhibition and administration of the antioxidant N-acetyl cysteine prevent these adverse effects. Interestingly, antioxidant treatment also prevents the increase in Nox expression, suggesting that β 2-adrenoceptor stimulation triggers a vicious cycle eventually amplified by both Nox isoforms. The possible existence of a circuitry to enhance ROS signalling and detrimental consequences on myocardial remodelling are also discussed, in light of the recent description of intracellular localization of Nox4.

Original languageEnglish (US)
Pages (from-to)1009-1011
Number of pages3
JournalBritish Journal of Pharmacology
Volume162
Issue number5
DOIs
StatePublished - Mar 2011

Keywords

  • congestive heart failure
  • oxidative stress
  • β /β -adrenoceptor

ASJC Scopus subject areas

  • Pharmacology

Fingerprint Dive into the research topics of 'β <sub>2</sub>-adrenoceptors, NADPH oxidase, ROS and p38 MAPK: Another 'radical' road to heart failure?'. Together they form a unique fingerprint.

Cite this